SFJ Pharmaceuticals, Inc.

ACTIVE

5000 Hopyard Rd Ste 330, 加利福尼亚州阿拉梅达县, California, United Stateswww.sfj-pharma.comHolding11–50 employeesEstablished: 2008-01-01

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2008

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

60.0%

Phase 2

20.0%

Phase 3

20.0%

Trial Status Distribution

Active, not recruiting

40.0%

Completed

40.0%

Recruiting

10.0%

Terminated

10.0%

Clinical Trials

Trials sponsored by this organization (10)

Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers

Phase 1

Terminated

interventional

Dec 202134 participants

A Study of PB2452 in Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure

Phase 1

Active, not recruiting

Dec 2020200 participants

A Study of PB2452 in Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure

Phase 1

Active, not recruiting

Nov 2020200 participants

A Study of PB2452 in Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure

Phase 1

Active, not recruiting

Oct 2020200 participants

A Study of PB2452 in Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure

Phase 1

Active, not recruiting

Oct 2020200 participants

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

Phase 3

Completed

interventional

Jul 2020226 participants

Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old

Phase 2

Completed

interventional

Sep 2019207 participants

Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects

Phase 2

Completed

interventional

Apr 201923 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations